States Push FDA To Hone Compounding Oversight Plan

Law360, New York (December 19, 2012, 7:09 PM ET) -- State officials expressed skepticism Wednesday about the U.S. Food and Drug Administration's plan to split oversight of compounding pharmacies following a deadly meningitis outbreak, saying different types of compounding should be more precisely defined.

The FDA convened a meeting with representatives from all 50 states after Commissioner Margaret Hamburg told lawmakers she wanted the agency to have jurisdiction over so-called nontraditional compounders, with states retaining jurisdiction over traditional compounders. Congress is considering an overhaul of compounding regulations in the wake of a meningitis outbreak linked to...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required